Omalizumab
- SubcutOmalizumabXolair
Mechanism of Action
- A humanised monoclonal antibody directed toward immunoglobulin E (IgE).
Clinical Use
- Indications
- Severe allergic asthma with elevated IgE
- Chronic spontaneous urticaria that is refractory to H1 antihistamines
- Adverse Effects
- Fevers
- Anaphylactoid reactions
- Headache
- Abdominal pain